Andrzej Lubiński

TL;DR: In all patients sinus rhythm was maintained at the end of the study period, however in 12 patients recurrence of AF was observed, confirmed by 24-hour ECG monitoring (atrial fibrillation recurrence group — AFR), while in 10 patients the episodes of arrhythmia were asymp- tomatic, while only 2 patients complained of arrHythmia symptoms.

TL;DR: Modification of the electric field during defibrillation, achieved with the use of active-can ICDs with dual-coildefibrillation leads, allows a reduction of DFT by 14%, which reduces the risk of a higher (> or =15 J) DFT in patients treated with an implantable cardioverter-defibrillator by three times compared to patients with a standard single-coiled lead.

TL;DR: In patients with a high DFT the use of reversed polarity of defibrillating impulse may reduce DFT, which widens the safety margin and makes implantation of additional leads unnecessary.

TL;DR: A limitation of the potential of prophylactic ICD therapy to improve survival in patients with diabetes with impaired left ventricular function is suggested.

TL;DR: Antazoline has an effect on electrophysiological parameters of the atrial muscle and has rapid onset of action and no negative effect on sinus node function and atrioventricular conduction in a unique property among antiarrhythmic drugs.